Exhale

The official blog of the Lung Institute.

COPD Sufferers, Get the Cellular Treatment Basics from the Lung Institute

9 Oct 2017
| Under COPD, Lung Disease | Posted by | 6 Comments

The Lung Institute’s remarkable cellular therapy that treats chronic obstructive pulmonary disease (COPD) is now available throughout the United States. This is not another drug. It’s a treatment!

Read More >

Traditional vs. Natural COPD Treatment: Your Complete Guide

8 Oct 2017
| Under COPD, Lifestyle, Treatments | Posted by | 11 Comments
Traditional vs. Natural COPD Treatment: Your Complete Guide

Knowing all of your COPD treatment options is important. When you have all of the information you need, you’re better able to make an informed decision about your healthcare. Keep reading to learn more about all of your COPD treatment options.

Read More >

What Are the Symptoms of Pulmonary Fibrosis?

22 Aug 2017
| Under Pulmonary Fibrosis | Posted by | 0 Comments
What Are the Symptoms of Pulmonary Fibrosis?

The most common symptom of pulmonary fibrosis is shortness of breath. In early stages, the condition often produces only mild breathlessness, which may be unnoticeable at first. Over time, as scar tissue continues to accumulate in the lungs, the associated breathing difficulties typically worsen. For instance, some individuals initially become winded during intense exercise, but…

Read More >

How Does Emphysema Affect Lung Function?

How Does Emphysema Affect Lung Function?

Emphysema affects lung function in three main ways. First, emphysema causes holes to gradually form inside the lungs’ air sacs, thereby weakening their internal structure and inhibiting the exchange of oxygen and carbon dioxide. Second, emphysema damages the elasticity of the airways that lead to the air sacs, causing the air sacs to collapse and…

Read More >

Is COPD a Progressive Disease?

8 Aug 2017
| Under COPD, Lung Disease | Posted by | 4 Comments
Lung Graphic

Chronic obstructive pulmonary disease, or COPD, is a progressive condition that is characterized by respiratory difficulties. Oftentimes, COPD results from a persistent cycle of emphysema and chronic bronchitis — emphysema causes the alveoli (air sacs in the lungs) to lose elasticity, and chronic bronchitis causes the bronchioles (air passages) to become inflamed, leading to increased…

Read More >

Review Your Treatment Options for Bronchiectasis

While not as common as other chronic lung diseases, bronchiectasis affects many people. Keep reading to learn about bronchiectasis treatment options here.

Read More >

COPD Treatment Success Stories

13 Jan 2017
| Under COPD, Lung Disease, Patient Stories, Treatments | Posted by | 23 Comments

Cellular treatment for COPD has helped many people feel better and breathe easier. Learn more and read their cellular treatment for COPD stories here.

Read More >

What is National COPD Awareness Month All About?

15 Nov 2016
| Under COPD, Lung Disease | Posted by | 0 Comments
National COPD Awareness Month

Learn more about National COPD Awareness Month, ways to become involved in the movement and how to raise awareness about COPD to improve care.

Read More >

This Week in Lung Disease: Air Quality at the Rio Olympics is Terrible

11 Aug 2016
| Under Lifestyle | Posted by | 4 Comments
This Week in Lung Disease: Air Quality at the Rio Olympics is Terrible

Each week, the Lung Institute takes a look at the trending stories in the world of lung disease. This week we look at the air quality at the Rio Olympics. Click the link to find out more.

Read More >

* Every patient is given a Patient Satisfaction Survey shortly after treatment. Responses to the 11-question survey are aggregated to determine patient satisfaction with the delivery of treatment.

^ Quality of Life Survey data measured the patient’s self-assessed quality of life and measurable quality of improvement at three months of COPD patients.

All claims made regarding the efficacy of Lung Institute's treatments as they pertain to pulmonary conditions are based solely on anecdotal support collected by Lung Institute. Individual conditions, treatment and outcomes may vary and are not necessarily indicative of future results. Testimonial participation is voluntary. Lung Institute does not pay for or script patient testimonials.

As required by Texas state law, the Lung Institute Dallas Clinic has received Institutional Review Board (IRB) approval from MaGil IRB, now Chesapeake IRB, which is fully accredited by the Association for the Accreditation of Human Research Protection Program (AAHRPP), for research protocols and procedures. The Lung Institute has implemented these IRB approved standards at all of its clinics nationwide. Approval indicates that we follow rigorous standards for ethics, quality, and protections for human research.

Each patient is different. Results may vary.